Epidemiology Study on Incidence Rate of Pneumococcal Pneumonia and Distribution of Streptococcus Pneumoniae Serotypes in Residents aged 18 Years or Older in Goto City in Japan.
- Conditions
- Community Acquired Pneumonia(CAP)
- Registration Number
- JPRN-UMIN000019961
- Lead Sponsor
- agasaki evaluation organization for clinical interventions
- Brief Summary
A total of 2,103 patients with CAP were enrolled; 84% were aged 65 years or older and 6.7% died during the study. The annual CAP, S pneumoniae CAP, 13-valent pneumococcal conjugate vaccine (PCV13) serotype CAP, and PCV20 serotype CAP incidences per 100,000 population were 1,280, 227, 63, and 110, respectively. S pneumoniae was detected in 17.8% of all patients with CAP by any detection method, with 4.9%, 5.5%, and 8.6% of cases of CAP resulting from PCV13, PCV15, and PCV20 serotypes, respectively.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 2103
Not provided
1) Any subject who is transferred to a participating medical institution after already being hospitalized for 48 hours or more at any other hospital 2) Hospital acquired pneumonia (ie, develops signs and symptoms of pneumonia after being hospitalized for 48 hours or more) 3) Subjects with either pneumococcal vaccine (PPV23 and/or PCV13) within the past 30 days 4) Previous enrollment in this study within the past 30 days
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method